Endoscopy Unit, Pulmonary Hospital, Zakopane, Poland
Endoscopy Unit, Pulmonary Hospital, Zakopane, Poland.
Pol Arch Intern Med. 2020 Aug 27;130(7-8):582-588. doi: 10.20452/pamw.15399. Epub 2020 May 28.
Needle biopsy of enlarged lymph nodes is an accepted method for the diagnostic workup of sarcoidosis, but the optimal endosonography‑guided approach is yet to be determined.
The aim of our study was to assess the relative diagnostic yield of combined ultrasound‑guided needle aspiration (CUS‑b‑NA), which includes endobronchial ultrasound‑guided transbronchial needle aspiration (EBUS‑TBNA) with endoscopic ultrasound fine‑needle aspiration (EUS‑b‑FNA), as well as the role of the cell block (CB) technique and lymph node localization in the diagnostic workup of sarcoidosis.
This was a prospective multicenter study including consecutive patients with clinical suspicion of stage I or II sarcoidosis. CUS‑b‑NA with smears and CB technique were performed in the whole study group. If a biopsy result was not conclusive, an invasive diagnostic workup and a 6-month follow‑up were scheduled.
Out of 77 screened patients, 54 signed written consent and 50 were enrolled for the final analysis. The overall sensitivity of EBUS‑TBNA, EUS‑b‑FNA, and CUS‑b‑NA was 76.6%, 70.2%, and 91.7%, respectively. There were no differences between EBUS‑TBNA and EUS‑b‑FNA (P = 0.52) but CUS‑b‑NA had a higher diagnostic yield (P = 0.005 and P = 0.001, respectively). Adding the CB method to smear technique (P = 0.008) and biopsy of the subcarinal lymph nodes increased the diagnostic yield (P = 0.001). Conclusions: The diagnostic yield of CUS‑b‑NA is higher than that of endosonographic techniques alone in the diagnostic workup of stage I and II sarcoidosis. The preparation of cytological material including CB and the choice of the subcarinal lymph node station for the biopsy increase the diagnostic efficacy.
经皮超声引导下的淋巴结细针抽吸活检术(FNAB)是诊断结节病的一种被广泛接受的方法,但最佳的内镜超声引导方法仍有待确定。
本研究旨在评估联合超声引导下针吸活检术(CUS-b-NA)的相对诊断收益,其包括经支气管超声引导下经支气管针吸活检术(EBUS-TBNA)联合内镜超声引导下细针抽吸活检术(EUS-b-FNA),以及细胞块(CB)技术和淋巴结定位在结节病诊断中的作用。
这是一项前瞻性多中心研究,纳入了临床疑似 I 期或 II 期结节病的连续患者。整个研究组均进行 CUS-b-NA 涂片和 CB 技术。如果活检结果不确定,则计划进行侵入性诊断性检查和 6 个月的随访。
在筛选出的 77 例患者中,54 例签署了书面同意书,50 例患者纳入最终分析。EBUS-TBNA、EUS-b-FNA 和 CUS-b-NA 的总体敏感性分别为 76.6%、70.2%和 91.7%。EBUS-TBNA 与 EUS-b-FNA 之间无差异(P = 0.52),但 CUS-b-NA 的诊断收益更高(P = 0.005 和 P = 0.001)。与涂片技术相比,增加 CB 方法(P = 0.008)和对隆突下淋巴结进行活检可提高诊断收益(P = 0.001)。
在 I 期和 II 期结节病的诊断中,CUS-b-NA 的诊断收益高于单纯的内镜超声引导技术。制备包括 CB 的细胞学材料以及选择隆突下淋巴结进行活检可提高诊断效果。